greeksoup/ stock research
Stock research / United States / AUPH / Planned sales

Aurinia Pharmaceuticals Inc. planned insider sales

In the last twelve months insiders at Aurinia Pharmaceuticals Inc. filed 7 Form 144 notices of planned sales, 4.5 million shares worth $124.4 million at the time of filing, from 5 sellers. The latest, filed 21 August 2026: Stephen P. Robertson (officer), 47,000 shares worth $719,100, planned for around 21 August 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services. One notice's value as filed does not match the share price that day; it is marked in the table.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
21 August 2026Stephen P. RobertsonOfficer47,000$719,10021 August 202632,914 shares from 21 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesPerformance Stock UnitsForm 144
5 June 2026Gregory KeenanFormer Affiliate9,593$158,4905 June 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Options Under a Registered PlanForm 144
4 June 2026Gregory KeenanFormer Affiliate25,000$408,4354 June 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Options Under a Registered PlanForm 144
2 June 2026Gregory KeenanOfficer25,000$54.1 million
value as filed; does not match the share price that day		2 June 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
11 May 2026Joseph MillerFormer Affiliate500,503$7.9 million11 May 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
11 May 2026Matthew Maxwell DonleyFormer Affiliate717,688$11.4 million11 May 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
11 May 2026Peter GreenleafFormer Affiliate3,136,201$49.7 million11 May 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?